The future of NMR-based metabolomics

John L. Markley, Rafael Brüschweiler, Arthur S. Edison, Hamid R. Eghbalnia, Robert Powers, Daniel Raftery, David S. Wishart

Research output: Contribution to journalReview article

205 Citations (Scopus)

Abstract

The two leading analytical approaches to metabolomics are mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Although currently overshadowed by MS in terms of numbers of compounds resolved, NMR spectroscopy offers advantages both on its own and coupled with MS. NMR data are highly reproducible and quantitative over a wide dynamic range and are unmatched for determining structures of unknowns. NMR is adept at tracing metabolic pathways and fluxes using isotope labels. Moreover, NMR is non-destructive and can be utilized in vivo. NMR results have a proven track record of translating in vitro findings to in vivo clinical applications.

Original languageEnglish (US)
Pages (from-to)34-40
Number of pages7
JournalCurrent Opinion in Biotechnology
Volume43
DOIs
StatePublished - Feb 1 2017

Fingerprint

Metabolomics
Magnetic Resonance Spectroscopy
Nuclear magnetic resonance
Mass spectrometry
Nuclear magnetic resonance spectroscopy
Mass Spectrometry
Isotopes
Labels
Fluxes
Metabolic Networks and Pathways

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Cite this

Markley, J. L., Brüschweiler, R., Edison, A. S., Eghbalnia, H. R., Powers, R., Raftery, D., & Wishart, D. S. (2017). The future of NMR-based metabolomics. Current Opinion in Biotechnology, 43, 34-40. https://doi.org/10.1016/j.copbio.2016.08.001

The future of NMR-based metabolomics. / Markley, John L.; Brüschweiler, Rafael; Edison, Arthur S.; Eghbalnia, Hamid R.; Powers, Robert; Raftery, Daniel; Wishart, David S.

In: Current Opinion in Biotechnology, Vol. 43, 01.02.2017, p. 34-40.

Research output: Contribution to journalReview article

Markley, JL, Brüschweiler, R, Edison, AS, Eghbalnia, HR, Powers, R, Raftery, D & Wishart, DS 2017, 'The future of NMR-based metabolomics', Current Opinion in Biotechnology, vol. 43, pp. 34-40. https://doi.org/10.1016/j.copbio.2016.08.001
Markley JL, Brüschweiler R, Edison AS, Eghbalnia HR, Powers R, Raftery D et al. The future of NMR-based metabolomics. Current Opinion in Biotechnology. 2017 Feb 1;43:34-40. https://doi.org/10.1016/j.copbio.2016.08.001
Markley, John L. ; Brüschweiler, Rafael ; Edison, Arthur S. ; Eghbalnia, Hamid R. ; Powers, Robert ; Raftery, Daniel ; Wishart, David S. / The future of NMR-based metabolomics. In: Current Opinion in Biotechnology. 2017 ; Vol. 43. pp. 34-40.
@article{a26bbb8352ef4fdbb36ccd304d7def98,
title = "The future of NMR-based metabolomics",
abstract = "The two leading analytical approaches to metabolomics are mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Although currently overshadowed by MS in terms of numbers of compounds resolved, NMR spectroscopy offers advantages both on its own and coupled with MS. NMR data are highly reproducible and quantitative over a wide dynamic range and are unmatched for determining structures of unknowns. NMR is adept at tracing metabolic pathways and fluxes using isotope labels. Moreover, NMR is non-destructive and can be utilized in vivo. NMR results have a proven track record of translating in vitro findings to in vivo clinical applications.",
author = "Markley, {John L.} and Rafael Br{\"u}schweiler and Edison, {Arthur S.} and Eghbalnia, {Hamid R.} and Robert Powers and Daniel Raftery and Wishart, {David S.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.copbio.2016.08.001",
language = "English (US)",
volume = "43",
pages = "34--40",
journal = "Current Opinion in Biotechnology",
issn = "0958-1669",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The future of NMR-based metabolomics

AU - Markley, John L.

AU - Brüschweiler, Rafael

AU - Edison, Arthur S.

AU - Eghbalnia, Hamid R.

AU - Powers, Robert

AU - Raftery, Daniel

AU - Wishart, David S.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - The two leading analytical approaches to metabolomics are mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Although currently overshadowed by MS in terms of numbers of compounds resolved, NMR spectroscopy offers advantages both on its own and coupled with MS. NMR data are highly reproducible and quantitative over a wide dynamic range and are unmatched for determining structures of unknowns. NMR is adept at tracing metabolic pathways and fluxes using isotope labels. Moreover, NMR is non-destructive and can be utilized in vivo. NMR results have a proven track record of translating in vitro findings to in vivo clinical applications.

AB - The two leading analytical approaches to metabolomics are mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Although currently overshadowed by MS in terms of numbers of compounds resolved, NMR spectroscopy offers advantages both on its own and coupled with MS. NMR data are highly reproducible and quantitative over a wide dynamic range and are unmatched for determining structures of unknowns. NMR is adept at tracing metabolic pathways and fluxes using isotope labels. Moreover, NMR is non-destructive and can be utilized in vivo. NMR results have a proven track record of translating in vitro findings to in vivo clinical applications.

UR - http://www.scopus.com/inward/record.url?scp=84983486892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983486892&partnerID=8YFLogxK

U2 - 10.1016/j.copbio.2016.08.001

DO - 10.1016/j.copbio.2016.08.001

M3 - Review article

C2 - 27580257

AN - SCOPUS:84983486892

VL - 43

SP - 34

EP - 40

JO - Current Opinion in Biotechnology

JF - Current Opinion in Biotechnology

SN - 0958-1669

ER -